ARW ON RNA

shocked surprised-GettyImages-1361394182 Two "Hot Takes" On mRNA Delivery

As I argued in a previous “Hot Take,” “the devil is in the details” when it comes to developing both our drug substances and our drug products. We need to get to the point where we have more details and knowledge about alternative methods of delivery (beyond LNPs) so we can make educated decisions on the best path forward for delivering our products. 

OUR EXPERT NETWORK

MEET ARW

Anna Rose

I’ve spent the past 10 years building relationships across the biologics and advanced therapies industry. In addition to hosting conversations and writing thought leadership articles, my goal as the editorial and community director for Advancing RNA is to find creative ways for the RNA (and broader ATMP) space to discuss, debate, and ultimately define a mature RNA therapeutics industry.    

Start the conversation by following me on LinkedIn!

FREE EBOOK: MODERNA'S REGULATORY JOURNEY

This collection of articles tells the story of how Moderna brought one of the first mRNA vaccines to the market and has all the makings of a legend we will pass down through generations. However, unlike the legends of King Arthur or The Fountain of Youth, we can celebrate that Moderna’s legendary journey was — and still is — real.